Treatment with BRAFi leads to MITF dependent regulation of PGC1α, which subsequently promotes mitochondrial biogenesis, OXPHOS and response to oxidative stress in BRAFV600 melanoma cells (Figure 2B,C) [55,56]. Here, MITF is linked to melanoma.